Gait Characteristics in Nondisabled Community-Residing Nonagenarians
Abstract
Kristhnamurthy M, Verghese J. Gait characteristics in nondisabled community-residing nonagenarians.
Objective
To determine gait performance in community-residing nonagenarians.
Design
Nested case-control study.
Setting
Community.
Participants
Thirty-one nondisabled nonagenarians (17 women) and 170 young-old controls (age range, 70−85y) participating in a longitudinal study.
Interventions
Not applicable.
Main Outcome Measures
Systematic clinical and quantitative gait assessments. We also examined the association of gait velocity with death over a 1-year period.
Results
Nonagenarian men had better performance on all quantitative gait parameters examined compared with women. Male sex (β=.58; 95% confidence interval [CI], 9.95−38.89) and depressive symptoms (β=−.34; 95% CI, −6.73 to −0.04) were independently associated with gait velocity in multivariate linear regression models. The 6 hypertensive nonagenarians on angiotensin-converting enzyme (ACE) inhibitors had faster gait velocity (median, 103.1cm/s) compared with the 8 hypertensive nonagenarians not on ACE inhibitors (median, 77.5cm/s; P=.029). Nonagenarians had worse quantitative gait parameters compared with the young-old controls, although the differences were less marked when subjects with clinically normal gaits in both groups were compared. Gait velocity did not predict survival over 1-year follow-up.
Conclusions
Gait characteristics in nondisabled community-residing nonagenarians are associated with male sex, depressive symptoms, and medications. The quantitative gait measures in this sample of nondisabled nonagenarians provide a yardstick to compare younger-age groups.
aDivision of Geriatrics, New York University Medical Center, New York, NY
bDepartment of Neurology, Albert Einstein College of Medicine, Bronx, NY
Reprints requests to Joe Verghese, MD, MS, Einstein Aging Study, Albert Einstein College of Medicine, 1165 Morris Park Ave, Rm 314, Bronx, NY 10461
Supported by the National Institutes on Aging (grant nos. AGO3949, RO1 AGO25119) and a Paul B. Beeson Career Development Award (grant no. K23 AG024848).
No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.